Literature DB >> 21193586

Decrease in the density of t-tubular L-type Ca2+ channel currents in failing ventricular myocytes.

Miwa Horiuchi-Hirose1, Toshihide Kashihara, Tsutomu Nakada, Nagomi Kurebayashi, Hisashi Shimojo, Toshihide Shibazaki, Xiaona Sheng, Shiharu Yano, Masamichi Hirose, Minoru Hongo, Takashi Sakurai, Tetsuji Moriizumi, Hideho Ueda, Mitsuhiko Yamada.   

Abstract

In some forms of cardiac hypertrophy and failure, the gain of Ca(2+)-induced Ca(2+) release [CICR; i.e., the amount of Ca(2+) released from the sarcoplasmic reticulum normalized to Ca(2+) influx through L-type Ca(2+) channels (LTCCs)] decreases despite the normal whole cell LTCC current density, ryanodine receptor number, and sarcoplasmic reticulum Ca(2+) content. This decrease in CICR gain has been proposed to arise from a change in dyad architecture or derangement of the t-tubular (TT) structure. However, the activity of surface sarcolemmal LTCCs has been reported to increase despite the unaltered whole cell LTCC current density in failing human ventricular myocytes, indicating that the "decreased CICR gain" may reflect a decrease in the TT LTCC current density in heart failure. Thus, we analyzed LTCC currents of failing ventricular myocytes of mice chronically treated with isoproterenol (Iso). Although Iso-treated mice exhibited intact t-tubules and normal LTCC subunit expression, acute occlusion of t-tubules of isolated ventricular myocytes with osmotic shock (detubulation) revealed that the TT LTCC current density was halved in Iso-treated versus control myocytes. Pharmacological analysis indicated that kinases other than PKA or Ca(2+)/calmodulin-dependent protein kinase II insufficiently activated, whereas protein phosphatase 1/2A excessively suppressed, TT LTCCs in Iso-treated versus control myocytes. These results indicate that excessive β-adrenergic stimulation causes the decrease in TT LTCC current density by altering the regulation of TT LTCCs by protein kinases and phosphatases in heart failure. This phenomenon might underlie the decreased CICR gain in heart failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193586     DOI: 10.1152/ajpheart.00508.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  17 in total

Review 1.  Mechanisms of altered Ca²⁺ handling in heart failure.

Authors:  Min Luo; Mark E Anderson
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 2.  Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytes.

Authors:  Jabe M Best; Timothy J Kamp
Journal:  J Mol Cell Cardiol       Date:  2011-08-23       Impact factor: 5.000

Review 3.  Calcineurin signaling in the heart: The importance of time and place.

Authors:  Valentina Parra; Beverly A Rothermel
Journal:  J Mol Cell Cardiol       Date:  2016-12-20       Impact factor: 5.000

4.  Angiotensin II activates CaV 1.2 Ca2+ channels through β-arrestin2 and casein kinase 2 in mouse immature cardiomyocytes.

Authors:  Toshihide Kashihara; Tsutomu Nakada; Katsuhiko Kojima; Toshikazu Takeshita; Mitsuhiko Yamada
Journal:  J Physiol       Date:  2017-04-20       Impact factor: 5.182

5.  Super-resolution scanning patch clamp reveals clustering of functional ion channels in adult ventricular myocyte.

Authors:  Mario Delmar; Julia Gorelik; Anamika Bhargava; Xianming Lin; Pavel Novak; Kinneri Mehta; Yuri Korchev
Journal:  Circ Res       Date:  2013-02-25       Impact factor: 17.367

Review 6.  Calcineurin in the heart: New horizons for an old friend.

Authors:  Malay Chaklader; Beverly A Rothermel
Journal:  Cell Signal       Date:  2021-08-25       Impact factor: 4.315

7.  Functional integrity of the T-tubular system in cardiomyocytes depends on p21-activated kinase 1.

Authors:  Jaime DeSantiago; Dan J Bare; Yunbo Ke; Katherine A Sheehan; R John Solaro; Kathrin Banach
Journal:  J Mol Cell Cardiol       Date:  2013-04-20       Impact factor: 5.000

8.  Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy.

Authors:  Bilge E Yamasan; Tanju Mercan; Orhan Erkan; Semir Ozdemir
Journal:  Cardiovasc Toxicol       Date:  2021-04-28       Impact factor: 3.231

9.  Dependence of cardiac transverse tubules on the BAR domain protein amphiphysin II (BIN-1).

Authors:  Jessica L Caldwell; Charlotte E R Smith; Rebecca F Taylor; Ashraf Kitmitto; David A Eisner; Katharine M Dibb; Andrew W Trafford
Journal:  Circ Res       Date:  2014-10-20       Impact factor: 17.367

Review 10.  Does Transient Receptor Potential Vanilloid Type 1 Alleviate or Aggravate Pathological Myocardial Hypertrophy?

Authors:  Qiqi Yan; Jun Tang; Xin Zhang; Liuyang Wu; Yunyi Xu; Lihong Wang
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.